New study seeks clues to why some get PAH and others Don't
NCT ID NCT05584722
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking at people with pulmonary arterial hypertension (PAH), those with a genetic risk but no disease, and healthy individuals. Researchers aim to find molecular and physical markers that explain why some people get PAH and others stay healthy. The goal is to improve early detection and identify new treatment targets.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify new targets for future treatments and help predict who is at risk for PAH.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may take years to apply.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY INDIVIDUALS WITH NO CARDIOPULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can bosentan reverse lung artery thickening? small study investigates
- Fat in the heart: new clues for PAH?
- Can a traditional chinese herb pill help Lung-Heart patients breathe easier?
- Virtual reality workouts tested for rare lung condition
- New PET tracer could spot deadly lung disease years earlier
- Researchers dive into why scleroderma and lung hypertension weaken the heart